These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 24631968
1. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats. Pałucha-Poniewiera A, Szewczyk B, Pilc A. Neuropharmacology; 2014 Jul; 82():59-68. PubMed ID: 24631968 [Abstract] [Full Text] [Related]
4. The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling. Bradley SR, Uslaner JM, Flick RB, Lee A, Groover KM, Hutson PH. Pharmacol Biochem Behav; 2012 Mar; 101(1):35-40. PubMed ID: 22138407 [Abstract] [Full Text] [Related]
5. NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice. Pomierny-Chamioło L, Poleszak E, Pilc A, Nowak G. Pharmacol Rep; 2010 Mar; 62(6):1186-90. PubMed ID: 21273676 [Abstract] [Full Text] [Related]
6. Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats. Podkowa K, Pochwat B, Brański P, Pilc A, Pałucha-Poniewiera A. Psychopharmacology (Berl); 2016 Aug; 233(15-16):2901-14. PubMed ID: 27286960 [Abstract] [Full Text] [Related]
7. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands. Gawel K, Jenda-Wojtanowska M, Gibula-Bruzda E, Kedzierska E, Filarowska J, Marszalek-Grabska M, Wojtanowski KK, Komsta L, Talarek S, Kotlinska JH. Physiol Behav; 2018 Mar 01; 185():112-120. PubMed ID: 29294304 [Abstract] [Full Text] [Related]
8. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent. Pałucha-Poniewiera A, Brański P, Lenda T, Pilc A. J Pharmacol Exp Ther; 2010 Sep 01; 334(3):1066-74. PubMed ID: 20562216 [Abstract] [Full Text] [Related]
9. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats. Koike H, Chaki S. Behav Brain Res; 2014 Sep 01; 271():111-5. PubMed ID: 24909673 [Abstract] [Full Text] [Related]
10. Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats. Pałucha-Poniewiera A, Podkowa K, Pilc A. Behav Pharmacol; 2019 Sep 01; 30(6):471-477. PubMed ID: 30724804 [Abstract] [Full Text] [Related]
11. The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice. Podkowa K, Pilc A, Podkowa A, Sałat K, Marciniak M, Pałucha-Poniewiera A. Neuropharmacology; 2018 Oct 01; 141():214-222. PubMed ID: 30145321 [Abstract] [Full Text] [Related]
12. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ. Eur Psychiatry; 2014 Sep 01; 29(7):419-23. PubMed ID: 24321772 [Abstract] [Full Text] [Related]
13. Antidepressant-like effect of the mGluR5 antagonist MTEP in an astroglial degeneration model of depression. Domin H, Szewczyk B, Woźniak M, Wawrzak-Wleciał A, Śmiałowska M. Behav Brain Res; 2014 Oct 15; 273():23-33. PubMed ID: 25043733 [Abstract] [Full Text] [Related]
14. Activation of the mGlu7 receptor elicits antidepressant-like effects in mice. Palucha A, Klak K, Branski P, van der Putten H, Flor PJ, Pilc A. Psychopharmacology (Berl); 2007 Nov 15; 194(4):555-62. PubMed ID: 17622518 [Abstract] [Full Text] [Related]
15. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist. Pałucha A, Brański P, Szewczyk B, Wierońska JM, Kłak K, Pilc A. Pharmacol Biochem Behav; 2005 Aug 15; 81(4):901-6. PubMed ID: 16040106 [Abstract] [Full Text] [Related]
16. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression. Koike H, Fukumoto K, Iijima M, Chaki S. Behav Brain Res; 2013 Feb 01; 238():48-52. PubMed ID: 23098797 [Abstract] [Full Text] [Related]
17. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists. Koike H, Iijima M, Chaki S. Neuropharmacology; 2011 Dec 01; 61(8):1419-23. PubMed ID: 21903115 [Abstract] [Full Text] [Related]
18. mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade. Dwyer JM, Lepack AE, Duman RS. Int J Neuropsychopharmacol; 2012 May 01; 15(4):429-34. PubMed ID: 22114864 [Abstract] [Full Text] [Related]
19. The role of mTOR in depression and antidepressant responses. Abelaira HM, Réus GZ, Neotti MV, Quevedo J. Life Sci; 2014 Apr 17; 101(1-2):10-4. PubMed ID: 24582593 [Abstract] [Full Text] [Related]
20. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling. Klodzinska A, Tatarczyńska E, Chojnacka-Wójcik E, Nowak G, Cosford ND, Pilc A. Neuropharmacology; 2004 Sep 17; 47(3):342-50. PubMed ID: 15275823 [Abstract] [Full Text] [Related] Page: [Next] [New Search]